Key indicators: single-crystal X-ray study; T = 295 K; mean (C-C) = 0.005 Å; R factor = 0.047; wR factor = 0.122; data-to-parameter ratio = 14.9.
Experimental
Crystal data Table 1 Hydrogen-bond geometry (Å , ). (Falcó et al., 2005) . Hydrogenated pyrazolo [3,4-b] pyridin-6-ones have been found with good biological activity such as GSK-3 inhibitors (Kung et al., 2007) and have the potential to be used as novel building blocks to construct new nitrogencontaining molecules. The title compound is one of the hydrogenated pyrazolo [3,4-b] pyridin-6-one derivatives. Its crystal structure is presented here.
In the title compound ( Fig. 1) there are four rings, three planar rings and one nonplanar hydrogenated pyridinone ring.
The hydrogenated pyridinone ring is fused to the pyrazole ring and adopts an envelope conformation with C4 at flap position. The dihedral angle between the bromo-substituted benzene ring and the pyrazole ring is 79.6 (1)° and that between the non-substituted phenyl ring and the pyrazole ring is 51.2 (1)°. cooling to room temperature, 5-amino-3-methyl-1-phenylpyrazole (1 mmol) was added and the mixture was stirred at room temperature for a certain period of time to complete the reaction (monitored by TLC). The reaction time was 9 h totally. Upon completion, the product was not separated from the reaction system; instead, 4 ml of ethanol was added. Single crystals of the title compound were obtained by slow evaporation of the solvent. 
